Errata (DOI:10.1016/S1470-2045(06)70943-3);Use of sirolimus for Epstein-Barr virus-positive smooth-muscle tumour

Lancet Oncology

Volumn 7, Issue 11, 2006, Pages 955-957

  Toh, Han Chong ^a   Teo, Marissa ^a   Ong, Kong Wee ^b   Lee, Victor ^c   Chan, Errol ^d   Lee, Ann SG ^a,d   Vathsala, Anantharaman ^b  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; EPSTEIN BARR VIRUS ANTIGEN; MAMMALIAN TARGET OF RAPAMYCIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PROTEIN KINASE B; RAPAMYCIN; SMOOTH MUSCLE ACTIN;

ADULT; ARTERY DISEASE; ARTICLE; CASE REPORT; CHINESE; DRUG USE; ECHOGRAPHY; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER NODULE; LIVER TUMOR; MAINTENANCE DRUG DOSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REMISSION; TUMOR IMMUNITY; TUMOR VOLUME;

EID: 33750326799     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(07)70055-4     Document Type: Erratum

References (14)

1. Creager A., Maia D., and Funkhouser W. Epstein-Barr Virus-associated renal smooth muscle neoplasm. Report of a case with review of the literature. Arch Pathol Lab Med 122 (1998) 277-281
2. Rogatsch H., Bonatti H., Menet A., et al. Epstein-Barr Virus-associated multicentric leiomyosarcoma in an adult patient after heart transplantation. Case report and review of the literature. Am J Surg Pathol 24 (2000) 614-621
3. Lee E., Locker J., Nalesnik M., et al. The association of Epstein-Barr virus with smooth muscle tumors occurring after organ transplantation. N Engl J Med 332 (1995) 19-25
4. Lorenzo F., Fraser R., Gaboury L., and Mulder D. Epstein-Barr virus-associated pulmonary leiomyosarcoma arising twenty-nine years after renal transplantation. J Thorac Cardiovasc Surg 126 (2003) 877-879
5. Suankratay C., Shuangshoti S., Mutirangura A., et al. Epstein-Barr virus infection-associated smooth-muscle tumors in patients with AIDS. HIV/AIDS 40 (2005) 1521-1528
6. Anguita J., Rico M., Palomo J., et al. Myocardial Epstein-Barr virus-associated cardiac smooth-muscle neoplasm arising in a cardiac transplant recipient. Transplantation 66 (1998) 400-401
7. Deyrup A., Lee V., Hill C., et al. Epstein-Barr Virus-associated smooth muscle tumors are distinctive mesenchymal tumors reflecting multiple infection events: a clinicopathologic and molecular analysis of 29 tumors from 19 patients. Am J Surg Pathol 30 (2006) 75-82
8. Cheuk W., Li P., and Chan J. Epstein-Barr virus-associated smooth muscle tumour: a distinctive mesenchymal tumour of immunocompromised individuals. Pathology 34 (2002) 245-249
9. Stallone G., Schena A., Infante B., et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 352 (2005) 1317-1323
10. Bonatti H., Hoefer D., Rogatsch H., et al. Successful management of recurrent Epstein-Barr Virus-associated multilocular leiomyosarcoma after cardiac transplantation. Transplant Proc 37 (2005) 1839-1844
11. Brown E., Albers M., Shin T., et al. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369 (1994) 756-758
12. Sekulic A., Hudson C., Homme J., et al. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res 60 (2000) 3504-3513
13. Gera J., Mellinghoff I., Shi Y., et al. AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression. J Biol Chem 279 (2004) 2737-2746
14. Vignot S., Faivre S., Aguirre D., and Raymond E. mTOR-targeted therapy of cancer with rapamycin derivatives. Ann Oncol 16 (2005) 525-537